LAURA NGUYEN: Open Payments
NPI 1710578190 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,731 in 105 payments from 17 companies in 2025. Trend: 2023 $1,310 · 2024 $2,615 · 2025 $1,731
Food & beverage: $1,731
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 36 | $336 |
| Amgen Inc. | 16 | $293 |
| Regeneron Healthcare Solutions, Inc. | 9 | $224 |
| Janssen Biotech, Inc. | 11 | $142 |
| Arcutis Biotherapeutics, Inc. | 1 | $115 |
| GENZYME CORPORATION | 3 | $91 |
| ABBVIE INC. | 5 | $87 |
| Galderma Laboratories, L.P. | 4 | $82 |
| Novartis Pharmaceuticals Corporation | 3 | $76 |
| E.R. Squibb & Sons, L.L.C. | 3 | $73 |
Products named: OTEZLA, DUPIXENT, ADBRY, TREMFYA, ANZUPGO, Zoryve, COSENTYX, Sotyktu.
Industry payments across TX — which companies pay providers there.
